Wearable artificial intelligence (AI) healthcare company SEERS is expanding its global footprint to Vietnam and Kazakhstan. The firm aims to commercialize its wearable electrocardiogram (ECG) analysis solution in Vietnam while exploring the potential implementation of its AI smart ward system in Kazakhstan.
SEERS announced on Tuesday that it had presented its AI inpatient monitoring platform thynC and smart ward implementation cases to a high-ranking delegation from Kazakhstan’s Ministry of Health during their visit to Korea on October 22.
The visit was arranged as part of the Kazakh delegation’s itinerary to observe best practices in digital healthcare while attending the World Bio Summit 2026. The seven-member delegation included Deputy Health Minister Yerbol Ospanov and officials from the Digital Healthcare Development Bureau, National Electronic Healthcare Center, and National Cancer Research Center.
SEERS showcased its thynC-based smart ward implementation at Dongtan City Hospital. The delegation showed keen interest in the system’s local applicability, with representatives from the National Cancer Research Center positively evaluating its potential use in Kazakh hospitals, according to company sources.
Both parties exchanged insights on long-term ECG testing systems and operational experiences. The Kazakh officials noted challenges in expanding long-term testing due to local Holter test pricing being based on a 24-hour standard. SEERS shared examples of long-term ECG monitoring implementation in Korea and discussed the potential local applications of thynC and its wearable ECG analysis solution mobiCARE.
In Vietnam, the commercialization of mobiCARE is gaining traction. Since its local launch in April, major medical institutions including the National Children’s Hospital (NCH), MEDLATEC, and Hung Vuong General Hospital have been consistently purchasing and prescribing the product.
SEERS is collaborating with local partners to establish remote ECG reading centers based in hospitals in Hanoi and Ho Chi Minh City. At the Asia Telemedicine Conference 2026 (ATS 2026) held in Hanoi on October 16, Chief Business Officer Kim Seong-jong presented on wearable AI-based patient monitoring technologies and their practical applications. The company plans to extend its operations to Thailand and Indonesia in the near future.
SEERS’ strategy involves identifying business opportunities in Southeast and Central Asia, in addition to enhancing its ongoing diagnostic service initiatives in the U.S. and the United Arab Emirates (UAE).
A SEERS spokesperson stated that it’s seeing mobiCARE’s commercialization gain momentum in Vietnam, while interest in the wearable AI healthcare solutions, including thynC, is growing in Kazakhstan. It aims to accelerate the global market expansion based on the proven technology and business models developed in Korea.
The name SEERS embodies the concept of a pioneer. It reflects the company’s founding philosophy of proactively envisioning changes in the healthcare landscape and developing innovative medical systems, even before digital healthcare became mainstream.
